Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway

Journal of Clinical Investigation

Volumn 119, Issue 9, 2009, Pages 2538-2549

  Cohen, Ethan David ^a   Ihida Stansbury, Kaori ^a   Lu, Min Min ^a   Panettieri, Reynold A ^a   Jones, Peter Lloyd ^a   Morrisey, Edward E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TENASCIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT7B PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL PROLIFERATION; CONTROLLED STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG DEVELOPMENT; LUNG DYSPLASIA; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SMOOTH MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; ASTHMA; BETA CATENIN; CELL PROLIFERATION; EMBRYONIC STEM CELLS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; PREGNANCY; PROTO-ONCOGENE PROTEINS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TENASCIN; WNT PROTEINS;

EID: 70349211744     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38079     Document Type: Article

References (40)

1. Cardoso, W.V., and Lu, J. 2006. Regulation of early lung morphogenesis: questions, facts and controversies. Development. 133:1611-1624. (Pubitemid 43810969)
2. Lane, K.B., et al. 2000. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat. Genet. 26:81-84.
3. Deng, Z., et al. 2000. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am. J. Hum. Genet. 67:737-744. (Pubitemid 30659603)
4. Zhang, Y., et al. 2008. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat. Genet. 40:862-870. (Pubitemid 351913647)
5. Wang, Z., Shu, W., Lu, M.M., and Morrisey, E.E. 2005. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol. Cell. Biol. 25:5022-5030. (Pubitemid 40781102)
6. Shu, W., et al. 2005. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung. Dev. Biol. 283:226-239. (Pubitemid 40828854)
7. Mucenski, M.L., et al. 2003. beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis. J. Biol. Chem. 278:40231-40238.
8. Shu, W., Jiang, Y.Q., Lu, M.M., and Morrisey, E.E. 2002. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development. 129:4831-4842. (Pubitemid 35277208)
9. Weidenfeld, J., Shu, W., Zhang, L., Millar, S.E., and Morrisey, E.E. 2002. The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. J. Biol. Chem. 277:21061-21070. (Pubitemid 34967417)
10. Jho, E.H., et al. 2002. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22:1172-1183.
11. Brault, V., et al. 2001. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 128:1253-1264. (Pubitemid 32409648)
12. Lepore, J.J., et al. 2005. High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice. Genesis. 41:179-184. (Pubitemid 40656689)
13. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., and Betsholtz, C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 126:3047-3055. (Pubitemid 29378170)
14. Cohen, E.D., et al. 2007. Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J. Clin. Invest. 117:1794-1804.
15. Hedgepeth, C.M., et al. 1997. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185:82-91.
16. Klein, P.S., and Melton, D.A. 1996. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U. S. A. 93:8455-8459.
17. Rajagopal, J., et al. 2008. Wnt7b stimulates embryonic lung growth by coordinately increasing the replication of epithelium and mesenchyme. Development. 135:1625-1634. (Pubitemid 351895492)
18. Ballagi, A.E., Ishizaki, A., Nehlin, J.O., and Funa, K. 1995. Isolation and characterization of the mouse PDGF beta-receptor promoter. Biochem. Biophys. Res. Commun. 210:165-173.
19. Jones, F.S., Meech, R., Edelman, D.B., Oakey, R.J., and Jones, P.L. 2001. Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmonary vascular disease. Circ. Res. 89:131-138. (Pubitemid 34135820)
20. Jones, P.L., Cowan, K.N., and Rabinovitch, M. 1997. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am. J. Pathol. 150:1349-1360. (Pubitemid 27152653)
21. Jones, P.L., and Rabinovitch, M. 1996. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ. Res. 79:1131-1142. (Pubitemid 26404145)
22. Jones, P.L., Crack, J., and Rabinovitch, M. 1997. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J. Cell Biol. 139:279-293. (Pubitemid 27444098)
23. Ihida-Stansbury, K., et al. 2006. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 291:L694-L702. (Pubitemid 44498481)
24. Haczku, A., et al. 2001. Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am. J. Respir. Cell Mol. Biol. 25:45-50. (Pubitemid 32682704)
25. Humbert, M., et al. 2004. Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 43:13S-24S. (Pubitemid 38233881)
26. Balasubramaniam, V., et al. 2003. Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L826-L833. (Pubitemid 36459029)
27. Schermuly, R.T., et al. 2005. Reversal of experimental pulmonary hypertension by PDGF inhibition. J. Clin. Invest. 115:2811-2821. (Pubitemid 41434408)
28. Kaarteenaho-Wiik, R., et al. 2002. Tenascin-C is highly expressed in respiratory distress syndrome and bronchopulmonary dysplasia. J. Histochem. Cytochem. 50:423-431. (Pubitemid 34171065)
29. Konigshoff, M., et al. 2008. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS ONE. 3:e2142. (Pubitemid 352025166)
30. Nakahara, H., et al. 2006. Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur. J. Immunol. 36:3334-3345. (Pubitemid 44932735)
31. Lewis, C.C., et al. 2003. Increased expression of platelet-derived growth factor receptor-beta in airway fibroblasts of severe asthmatics. Chest. 123:428S-429S.
32. Matsuda, A., et al. 2005. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum. Mol. Genet. 14:2779-2786. (Pubitemid 41418784)
33. Mucenski, M.L., et al. 2005. Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 289:L971-L979. (Pubitemid 41681332)
34. Wu, L.S., Tan, C.Y., Wang, L.M., Lin, C.G., and Wang, J.Y. 2006. Variant in promoter region of platelet-derived growth factor receptor-alpha (PDGFRalpha) gene is associated with the severity and allergic status of childhood asthma. Int. Arch. Allergy Immunol. 141:37-46.
35. De Langhe, S.P., et al. 2005. Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung. Dev. Biol. 277:316-331.
36. Parr, B.A., Avery, E.J., Cygan, J.A., and McMahon, A.P. 1998. The classical mouse mutant postaxial hemimelia results from a mutation in the Wnt 7a gene. Dev. Biol. 202:228-234.
37. Li, C., Xiao, J., Hormi, K., Borok, Z., and Minoo, P. 2002. Wnt5a participates in distal lung morphogenesis. Dev. Biol. 248:68-81. (Pubitemid 34925869)
38. Li, C., et al. 2005. Wnt5a regulates Shh and Fgf10 signaling during lung development. Dev. Biol. 287:86-97. (Pubitemid 41587480)
39. Que, J., et al. 2008. Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. Proc. Natl. Acad. Sci. U. S. A. 105:16626-16630.
40. Maretto, S., et al. 2003. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. U. S. A. 100:3299-3304. (Pubitemid 36356577)